Globus Medical saw nearly $3 billion in full-year net sales, according to financial results posted Feb. 24.
Five things to know:
1. Net sales in 2025 were $2.93 billion, an increase of 16.7% year over year. Base business sales excluding Nevro were $2.64 billion.
2. Musculoskeletal solutions sales in 2025 were $2.8 billion in 2025, and enabling technologies sales were $141 million.
3. The fourth quarter of 2025 also saw revenue gains with $826.4 million, a 25.7% increase.
4. Globus Medical is reaffirming its guidance for 2026 sales and expects full year sales to reach $3.18 billion to $3.22 billion.
5. CEO Keith Pfeil said: “We delivered above market, top-line growth, across the portfolio, including our core spine franchise, while delivering meaningful margin expansion – reflecting disciplined execution. Looking ahead to 2026, our focus lies in driving durable momentum, centered on scaling growth and sustainable operating leverage. We are confident in our ability to launch a robust new product pipeline and expand our high-touch sales force, while maintaining speed and agility, as we realize our long-term goal of addressing unmet clinical needs with differentiated procedural solutions. We are focused on achieving improved surgical outcomes through the Globus surgical intelligence closed loop ecosystem, bringing together patient selection, surgical techniques and complementary implants.”
